SCHEMBL14745361

SCHEMBL14745361

CCc1c(-c2ccc(C)cc2)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccccc2N2CCCCC2)[nH]c(=O)c(C(=O)O)c1O

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
NPY5R Q15761 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGS2 P35354 1/20 0.36
POLB P06746 3/20 0.36
TSHR P16473 1/20 0.36
KIF11 P52732 1/20 0.35
TACR1 P25103 2/20 0.35
KMO O15229 1/20 0.34
TNKS2 Q9H2K2 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14745626 0.92 ALDH1A1 (0.41) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL14747045 0.91 KMT2A (0.40) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL14745363 0.91 MEN1 (0.36) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL17594964 0.83 ALDH1A1 (0.35) MEN1KMT2AALDH1A1SMN1; SMN2LMNA
SCHEMBL14745564 0.82 KIF11 (0.42) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL14741215 0.82 KDM4E (0.39) GAAKDM4E
SCHEMBL14744987 0.82 ALDH1A1 (0.37) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL14747044 0.81 KIF11 (0.41) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL14744809 0.81 ALDH1A1 (0.36) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2
SCHEMBL14745174 0.79 KCNH2 (0.40) MEN1KMT2ANPY5RALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016039936-A2 MONOCYCLIC SUBSTITUTED 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO claimed
EP-2750505-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC Therapeutics, Inc. (US) 2014-07-09 EP disclosed
WO-2013033240-A1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS, INC. (US) 2013-03-07 WO disclosed